D H Watts
Overview
Explore the profile of D H Watts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
1179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Best B, Burchett S, Li H, Stek A, Hu C, Wang J, et al.
HIV Med
. 2015 May;
16(8):502-11.
PMID: 25959631
Objectives: Tenofovir disoproxil fumarate (TDF) is increasingly used in the highly active antiretroviral therapy (HAART) regimens of pregnant women, but limited data exist on the pregnancy pharmacokinetics of chronically dosed...
2.
Kreitchmann R, Li S, Melo V, Fernandes Coelho D, Watts D, Joao E, et al.
BJOG
. 2014 Mar;
121(12):1501-8.
PMID: 24602102
Objective: To examine maternal characteristics associated with adverse pregnancy outcomes among women infected with HIV. Design: Prospective cohort study. Setting: Multiple sites in Latin America and the Caribbean. Population: Women...
3.
Watts D, Lu M, Thompson B, Tuomala R, Meyer 3rd W, Mendez H, et al.
Infect Dis Obstet Gynecol
. 2009 Nov;
2009:456717.
PMID: 19893751
Objective: To assess clinical progression and inflammatory markers among women stopping or continuing antiretroviral therapy (ART) after pregnancy. Methods: ART-naïve women with CD4+ lymphocyte counts >350 cells/uL initiating ART during...
4.
Bryson Y, Mirochnick M, Stek A, Mofenson L, Connor J, Capparelli E, et al.
HIV Clin Trials
. 2008 May;
9(2):115-25.
PMID: 18474496
Background: Combination antiretroviral regimens including nelfinavir (NFV) are commonly used in pregnancy. We studied the safety, antiviral effect, and pharmacokinetics of NFV and its M8 metabolite with two dosing regimens...
5.
Cohn S, Park J, Watts D, Stek A, Hitti J, Clax P, et al.
Clin Pharmacol Ther
. 2006 Dec;
81(2):222-7.
PMID: 17192768
We conducted an open-label, steady-state pharmacokinetic (PK) study of drug interactions among HIV-infected women treated with depo-medroxyprogesterone acetate (DMPA) while on nucleoside analogues plus nelfinavir (N=21), efavirenz (N=17), or nevirapine...
6.
Eckert L, Watts D, Thwin S, Kiviat N, Agnew K, Eschenbach D
Obstet Gynecol
. 2003 Dec;
102(5 Pt 1):962-9.
PMID: 14672471
Objective: To estimate the prevalence, risk factors, clinical symptoms and signs, and response to antimicrobial therapy of histologic endometritis in human immunodeficiency virus (HIV)-infected women without clinical salpingitis. Methods: This...
7.
Minkoff H, Ahdieh L, Massad L, Anastos K, Watts D, Melnick S, et al.
AIDS
. 2001 Oct;
15(16):2157-64.
PMID: 11684935
Objective: Cervical intraepithelial neoplasia (CIN), a common condition among HIV-infected women, has been linked to HIV load and immune status. Highly active antiretroviral therapy (HAART) improves immunologic and virologic status....
8.
9.
Cu-Uvin S, Wright D, Anderson D, Kovacs A, Watts D, Cohn J, et al.
J Womens Health Gend Based Med
. 2000 Nov;
9(8):857-63.
PMID: 11074951
There is a paucity of normative data on hormonal levels among HIV-infected women. Hormonal levels may influence fertility and HIV-related immunological and virological factors. The objective of this study was...
10.
Dublin S, Lydon-Rochelle M, Kaplan R, Watts D, Critchlow C
Am J Obstet Gynecol
. 2000 Oct;
183(4):986-94.
PMID: 11035351
Objective: This study was undertaken to examine associations between induction of labor and maternal and neonatal outcomes among women without an identified indication for induction. Study Design: This was a...